- 专利标题： ARYLSULFONAMIDE CCR3 ANTAGONISTS
-
申请号： US13050831申请日： 2011-03-17
-
公开(公告)号： US20110230487A1公开(公告)日： 2011-09-22
- 发明人: Tai Wei LY , Garrett Thomas Potter , Jared Andrew Forrester
- 申请人： Tai Wei LY , Garrett Thomas Potter , Jared Andrew Forrester
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; C07D211/96 ; A61K31/4468 ; C07D401/12 ; A61K31/454 ; C07D413/12 ; C07D401/04 ; A61K31/4545 ; A61K31/496 ; A61P11/00 ; A61P37/08 ; A61P1/00 ; A61P17/00 ; A61P25/28 ; A61P9/00 ; A61P19/02 ; C12N5/07
摘要：
Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
公开/授权文献
- US08741894B2 Arylsulfonamide CCR3 antagonists 公开/授权日：2014-06-03
信息查询
IPC分类:
